Peaches Biotech, Universidad Autónoma of Madrid and its Foundation create the first University Chair in Advanced Therapies based on cell secretomes
- The UAM-Peaches Chair will promote research and teaching in the areas of Cellular Therapy and Regenerative Medicine
- One of the priority objectives is the search for alternatives to cell therapies, based on the use of the secretomes that the stem cells themselves emit to signal and carry out their repair and regenerative function.
It’s been created the PEACHES-UAM Chair between the Universidad Autónoma of Madrid (UAM), the Foundation of this University (FUAM) and Peaches Biotech Group with the goal of promoting research, teaching and dissemination of knowledge in the field of Cellular Therapy and Regenerative Medicine, particularly in matters related to the development of new drugs for advanced therapies and specifically mesenchymal stem cells derived from adipose tissues and their production capacity.
The Chair, directed by professors Damián García Olmo and Mariano García Arranz, is linked to the Department of Surgery of the Faculty of Medicine of the UAM.
Peaches Biotech brings to this Chair its research experience. A platform to produce next-generation complex biological drugs based on cell co-culture, a procedure that involves the use of stem cells and their secretomes as biological elements of cell signaling in different types of tissues.
This drug selectively signals the tissue and produces a very fast and highly effective tissue regeneration. Moreover, being a set of cytokines of human origin, they are easily freeze-dried, transportable and storable in such a way that they solve classical problems of frozen cells and considerably reduce production and distribution costs, making the drug more accessible to physicians and patients in the near future. It will be a paradigm shift in musculoskeletal treatments.
*More information on the file attached